Home
Conditions
Lymphoma, Non-Hodgkin

Clinical trial condition

Lymphoma, Non-Hodgkin

Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.

1,630 public trials 214 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma, Non-Hodgkin trial results

Completed

Safety and Efficacy Study of BCD-020 in Therapy of Indolent Non-Hodgkin's Lymphoma

NCT01701232

Conditions: Follicular Non-Hodgkin's Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations: Instituto Nacional de Cancerología Bogotá, Colombia

Fundación Reina Isabel Cali, Colombia

Hospital Pablo Tobon Uribe Medellín, Colombia

HCG Multi Specialty Hospitals Ahmedabad, India

View all 62 locations

View Trial Details

Completed

Phase 1 Every-3-Week Dosing of SCH 727965 in Patients With Advanced Cancer (Study P04630)

NCT00871910

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
Locations: Not specified

View Trial Details

Completed

A Phase II Study for Patients With Indolent Non-follicular Non-Hodgkin's Lymphoma

NCT01929265

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: SC Ematologia - AO SS. Antonio e Biagio e C. Arrigo Alessandria, AL, Italy

SC Ematologia Spedali Civili Brescia, BS, Italy

Divisione di Ematologia e Trapianti, Ospedale San Maurizio Bolzano, BZ, Italy

Divisione di Ematologia, Centro Trapianto di Cellule Staminali San Giovanni Rotondo, Foggia, Italy

View all 25 locations

View Trial Details

Completed

Using Telephone Counselling to Improve Exercise Participation in Hematologic Cancer Survivors

NCT03052777

Conditions: Behavior, Behavior, Health, Health Behavior, +11 more
Locations: University of Alberta Edmonton, Alberta, Canada

View Trial Details

Completed

CAT-8015 in Children, Adolescents and Young Adults With Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma

NCT00659425

Conditions: Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +12 more
Locations: Research Site Los Angeles, California, United States

Research Site Bethesda, Maryland, United States

Research Site Boston, Massachusetts, United States

Research Site Memphis, Tennessee, United States

View Trial Details

Completed

Busulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer

NCT00245037

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +81 more
Locations: Knight Cancer Institute at Oregon Health and Science University Portland, Oregon, United States

View Trial Details

Completed

Busulfan, Melphalan, and Thiotepa in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Hodgkin's or Non-Hodgkin's Lymphoma

NCT00238433

Conditions: Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +37 more
Locations: Knight Cancer Institute at Oregon Health and Science University Portland, Oregon, United States

View Trial Details

Completed

Lenalidomide After Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic Cancers

NCT01254578

Conditions: Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11, Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11, Adult Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1, +96 more
Locations: Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details

Completed

Study of Radiolabeled Monoclonal Antibody Anti-B1 for the Treatment of B-Cell Lymphomas and Extended Study to Determine the Safety and Efficacy of Coulter Clone® 131Iodine-B1 Radioimmunotherapy of Advanced Non-Hodgkin's Lymphoma

NCT01536561

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: Not specified

View Trial Details

Completed

Iodine I 131 Tositumomab, Etoposide and Cyclophosphamide Followed by Autologous Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

NCT00073918

Conditions: Anaplastic Large Cell Lymphoma, Blood Protein Disorders, Burkitt Lymphoma, +50 more
Locations: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Lymphoma, Non-Hodgkin

Lymphoma, Non-Hodgkin trial results

Related conditions